$19,026.64 research Payment -- Teva Pharmaceuticals to Dr. Karen Harris

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Teva Pharmaceuticals made a $19.0K research payment to Karen Harris, a Psychiatry specialist in Sacramento, CA. The total payment amount of $19,026.64 was made for research purposes. This payment was made by Teva Pharmaceuticals to Dr. Karen Harris, a psychiatrist in Sacramento, CA. The payment was processed on January 13, 2026.

Patient Guidance: What This Payment Means for You

This payment was for research activities and does not represent a direct payment for medical services to patients. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for research in psychiatry can vary widely depending on the scope and duration of the study.

Regulatory Context: Sunshine Act Requirements

This payment is subject to reporting requirements under the Sunshine Act, which mandates disclosure of payments made by drug and device manufacturers to physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• research-funding
• psychiatry
• cms-open-payments
• drug-company-payments
• physician-compensation

Understanding research Payments

Research payments fund clinical trials, research studies, and investigator-initiated research conducted by physicians. These payments are often the largest category and represent a critical part of the drug development process. Research funding is generally considered the most legitimate form of pharmaceutical payment, though potential conflicts of interest can still arise when researchers have financial relationships with the companies whose products they study.

Frequently Asked Questions About This Payment

What was this $19.0K payment for?

This was a research payment of $19.0K from Teva Pharmaceuticals to Karen Harris, categorized as "Research". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Karen Harris accept pharmaceutical money?

Yes, Karen Harris received this $19.0K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Karen Harris's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this research payment?

A research payment of $19.0K typically funds clinical studies and is considered standard academic activity. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Psychiatry?

To compare this payment against Psychiatry averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Psychiatry physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Karen Harris's relationship with Teva Pharmaceuticals?

The payment is categorized under 'research' and specifically as 'Research'. This $19.0K research payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Psychiatry?

The payment ID is OP-MNK3Y9P5-4TYZOC.

What should patients do after learning about this payment?

This payment was for research activities and does not represent a direct payment for medical services to patients.

What else should I know about this research payment?

Dr. Harris's NPI is 1494040715.

Related Reports

• View Dr. Karen Harris's full payment report
• Teva Pharmaceuticals full spending report
• Browse all Psychiatry payments
• Browse all payments in California
• Search for other payments